Practice Management

Top Story

Memorial Sloan Kettering Cancer Center names head of solid tumor oncology

Memorial Sloan Kettering Cancer Center names head of solid tumor oncology
April 26, 2017

Luis A. Diaz, MD, has been named head of the division of solid tumor oncology in the department of medicine at Memorial Sloan Kettering Cancer Center.

Diaz — whose interests include cancer genetics and immuno-oncology — will continue his clinical practice with the center’s gastrointestinal oncology service. He specializes in the treatment of colorectal and pancreatic cancers.

In the Journals Plus

Longer telomeres associated with increased cancer risk

April 26, 2017
Longer telomeres appeared to increase the risk for various cancers, but reduced the risk for non-neoplastic diseases, including cardiovascular diseases, according to
FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer. The…
In the Journals Plus

Collection of patient-reported symptoms, adverse events ‘highly feasible’ during clinical trials

April 24, 2017
Patient reports of their own symptomatic adverse events during multicenter clinical cancer trials proved possible and led to improved efficacy and safety monitoring in…
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: How a physician can perform well in MIPS

March 23, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »

Memorial Sloan Kettering Cancer Center names head of solid tumor oncology

April 26, 2017
Luis A. Diaz, MD, has been named head of the division of solid tumor oncology in the department of medicine at Memorial Sloan Kettering Cancer…

In the Journals Plus

Longer telomeres associated with increased cancer risk

April 26, 2017
Longer telomeres appeared to increase the risk for various cancers, but reduced the risk for non-neoplastic diseases, including cardiovascular

FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or…

In the Journals Plus

Collection of patient-reported symptoms, adverse events ‘highly feasible’ during clinical trials

April 24, 2017
Patient reports of their own symptomatic adverse events during multicenter clinical cancer trials proved possible and led to improved efficacy and…

Editorial

Peter C. Nowell, MD (1928-2016): Loss of an icon and iconoclast

HemOnc Today, April 25, 2017
Derek Raghavan, MD, PhD
I usually am saddened when I read of the passing of a scientific icon. However, the loss of Peter C. Nowell, MD, on Dec. 26 at the age of 88 years…

Roswell Park Cancer Institute names department chairman

April 23, 2017
John Krolewski , MD, PhD, has been named chair of the department of cancer genetics and genomics at Roswell Park Cancer Institute…

Association of Community Cancer Centers names 2017-2018 president

April 22, 2017
Mark S. Soberman , MD, MBA, FACS, has been elected president of the Association of Community Cancer Centers for the 2017-2018 term…

Longitudinal study launched to help determine transition from health to disease

April 21, 2017
Verily Life Sciences LLC announced the launch of a 4-year study in partnership with Duke University School of Medicine and Stanford Medicine to gain…

AMA, collaborators provide ‘bold, innovative’ EHR training

April 21, 2017
The AMA recently announced a partnership with the Regenstrief Institute that it says will ensure more medical students and medical trainees gain…

MD Anderson immunology chair among Time magazine’s 100 most influential people

April 20, 2017
James P. Allison, PhD, chair of the department of immunology at The University of Texas MD Anderson Cancer Center, has been named to Time

More Headlines »
Advertisement
Advertisement